Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial
Journal article
Luvira V. et al, (2024), BMC Infectious Diseases, 24
Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV)
Journal article
Jittamala P. et al, (2023), The Journal of Infectious Diseases
Raising awareness of antimicrobial resistance: development of an ‘antibiotic footprint calculator’
Journal article
Prapharsavat R. et al, (2023), Journal of Antimicrobial Chemotherapy, 78, 1317 - 1321
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)
Journal article
Schilling WHK. et al, (2023), eLife, 12
Good participatory practice for coronavirus disease 2019 (COVID-19) research: the case of a COVID-19 prevention study
Journal article
Perrone C. et al, (2022), Wellcome Open Research, 6, 216 - 216
Defining the burden of febrile illness in rural South and Southeast Asia: an open letter to announce the launch of the Rural Febrile Illness project
Journal article
Chandna A. et al, (2022), Wellcome Open Research, 6, 64 - 64
Good participatory practice for coronavirus disease 2019 (COVID-19) research: the case of a COVID-19 prevention study.
Journal article
Perrone C. et al, (2021), Wellcome open research, 6